Application and validation of the bodily distress syndrome checklist in a psychosomatic outpatient sample

Standard

Application and validation of the bodily distress syndrome checklist in a psychosomatic outpatient sample. / Wertenbruch-Rocke, Tina; Hüsing, Paul; Löwe, Bernd; Toussaint, Anne.

in: GEN HOSP PSYCHIAT, Jahrgang 69, 16.02.2021, S. 104-110.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{8eabdf345a224ed4986cab8065f50345,
title = "Application and validation of the bodily distress syndrome checklist in a psychosomatic outpatient sample",
abstract = "OBJECTIVE: The BDS checklist is a self-report measure to assess the most common somatic symptoms in functional somatic syndromes, based on the diagnostic concept of Bodily Distress Syndrome. The aim of the study was to examine the psychometric properties and validity of the BDS checklist in a psychosomatic sample and to investigate whether it is suitable to detect DSM-5 somatic symptom disorders (SSD).METHOD: In a cross-sectional study, n = 368 patients from a psychosomatic outpatient clinic completed the BDS checklist and a semi-structured clinical interview on SSD. Item and scale characteristics and measures of reliability and validity were determined.RESULTS: The BDS checklist showed good item characteristics and reliability (Cronbach α = 0.89). Factor analysis confirmed four symptom clusters (CFI = 0.95, TLI = 0.95, RMSEA = 0.091, 90% CI = 0.085-0.097). The BDS total score showed significant correlations with other measures of somatic symptom burden (r = 0.79, p < .001), health anxiety (r = 0.46, p < .001), depression (r = 0.45, p < .001), and general anxiety (r = 0.41, p < .001). Higher BDS checklist scores were associated with higher physical and mental health impairment and higher health care use. Diagnostic accuracy regarding somatic symptom disorder was moderate (AUC = 0.72, 95% CI: 0.67-0.77).CONCLUSION: Findings of our study indicate that the BDS checklist is a reliable and valid measure to assess the most common somatic symptoms in a psychosomatic setting. It is however not sufficient to detect persons at risk for somatic symptom disorder. A combination with further questionnaires could probably improve diagnostic accuracy.",
author = "Tina Wertenbruch-Rocke and Paul H{\"u}sing and Bernd L{\"o}we and Anne Toussaint",
note = "Copyright {\textcopyright} 2020. Published by Elsevier Inc.",
year = "2021",
month = feb,
day = "16",
doi = "10.1016/j.genhosppsych.2020.12.005",
language = "English",
volume = "69",
pages = "104--110",
journal = "GEN HOSP PSYCHIAT",
issn = "0163-8343",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Application and validation of the bodily distress syndrome checklist in a psychosomatic outpatient sample

AU - Wertenbruch-Rocke, Tina

AU - Hüsing, Paul

AU - Löwe, Bernd

AU - Toussaint, Anne

N1 - Copyright © 2020. Published by Elsevier Inc.

PY - 2021/2/16

Y1 - 2021/2/16

N2 - OBJECTIVE: The BDS checklist is a self-report measure to assess the most common somatic symptoms in functional somatic syndromes, based on the diagnostic concept of Bodily Distress Syndrome. The aim of the study was to examine the psychometric properties and validity of the BDS checklist in a psychosomatic sample and to investigate whether it is suitable to detect DSM-5 somatic symptom disorders (SSD).METHOD: In a cross-sectional study, n = 368 patients from a psychosomatic outpatient clinic completed the BDS checklist and a semi-structured clinical interview on SSD. Item and scale characteristics and measures of reliability and validity were determined.RESULTS: The BDS checklist showed good item characteristics and reliability (Cronbach α = 0.89). Factor analysis confirmed four symptom clusters (CFI = 0.95, TLI = 0.95, RMSEA = 0.091, 90% CI = 0.085-0.097). The BDS total score showed significant correlations with other measures of somatic symptom burden (r = 0.79, p < .001), health anxiety (r = 0.46, p < .001), depression (r = 0.45, p < .001), and general anxiety (r = 0.41, p < .001). Higher BDS checklist scores were associated with higher physical and mental health impairment and higher health care use. Diagnostic accuracy regarding somatic symptom disorder was moderate (AUC = 0.72, 95% CI: 0.67-0.77).CONCLUSION: Findings of our study indicate that the BDS checklist is a reliable and valid measure to assess the most common somatic symptoms in a psychosomatic setting. It is however not sufficient to detect persons at risk for somatic symptom disorder. A combination with further questionnaires could probably improve diagnostic accuracy.

AB - OBJECTIVE: The BDS checklist is a self-report measure to assess the most common somatic symptoms in functional somatic syndromes, based on the diagnostic concept of Bodily Distress Syndrome. The aim of the study was to examine the psychometric properties and validity of the BDS checklist in a psychosomatic sample and to investigate whether it is suitable to detect DSM-5 somatic symptom disorders (SSD).METHOD: In a cross-sectional study, n = 368 patients from a psychosomatic outpatient clinic completed the BDS checklist and a semi-structured clinical interview on SSD. Item and scale characteristics and measures of reliability and validity were determined.RESULTS: The BDS checklist showed good item characteristics and reliability (Cronbach α = 0.89). Factor analysis confirmed four symptom clusters (CFI = 0.95, TLI = 0.95, RMSEA = 0.091, 90% CI = 0.085-0.097). The BDS total score showed significant correlations with other measures of somatic symptom burden (r = 0.79, p < .001), health anxiety (r = 0.46, p < .001), depression (r = 0.45, p < .001), and general anxiety (r = 0.41, p < .001). Higher BDS checklist scores were associated with higher physical and mental health impairment and higher health care use. Diagnostic accuracy regarding somatic symptom disorder was moderate (AUC = 0.72, 95% CI: 0.67-0.77).CONCLUSION: Findings of our study indicate that the BDS checklist is a reliable and valid measure to assess the most common somatic symptoms in a psychosomatic setting. It is however not sufficient to detect persons at risk for somatic symptom disorder. A combination with further questionnaires could probably improve diagnostic accuracy.

U2 - 10.1016/j.genhosppsych.2020.12.005

DO - 10.1016/j.genhosppsych.2020.12.005

M3 - SCORING: Journal article

C2 - 33588195

VL - 69

SP - 104

EP - 110

JO - GEN HOSP PSYCHIAT

JF - GEN HOSP PSYCHIAT

SN - 0163-8343

ER -